The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.

Emerging Market Debt offers higher spreads and a better risk/return profile compared to developed market debt, making it a valuable portfolio addition. Despite past headwinds like a strong USD, EMD's ...

As American Merck (MSD) accelerates its plan to launch the cancer drug Keytruda in a subcutaneous injection (SC) formulation instead of an intravenous injection (IV), a patent dispute has erupted over ...

In 2021, to address the continuing musculoskeletal disorders, or MSDs, which are the most common workplace injury, the National Safety Council created the MSD Solutions Lab. The cost of these injuries ...